Consolidated Statements Of Cash Flows (USD $) In Thousands	3 Months Ended
	Jun. 18, 2011	Jun. 19, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (157,161)	$ (122,643)
Adjustments to reconcile net loss to net cash used in operating activities	92,890	82,782
Other changes in assets and liabilities:
Decrease in receivables	47,920	4,139
Decrease (increase) in inventories	26,573	(4,401)
(Increase) decrease in prepaid expenses and other current assets	(2,039)	1,209
Increase in other assets	(4,487)	(1,224)
(Decrease) increase in accounts payable	(21,151)	1,584
(Decrease) increase in accrued salaries, wages and benefits, and taxes	(1,853)	2,059
Increase (decrease) in other accruals	67,753	(1,763)
Decrease in other non-current liabilities	(67,943)	(19,978)
Other operating activities, net	(113)	(29)
Payment for reorganization items	(11,304)
Net cash used in operating activities	(30,915)	(58,265)
CASH FLOWS FROM INVESTING ACTIVITIES:
Expenditures for property	(11,177)	(19,668)
Proceeds from disposal of property	6,805	1,677
Decrease in restricted cash		302
Proceeds from sale of pharmacy assets	2,821
Net cash used in investing activities	(1,551)	(17,689)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt		800
Principal payments on long-term debt	(55)	(69)
Principal payments on long-term real estate liabilities	(355)	(383)
Principal payments on capital leases	(3,360)	(3,775)
(Decrease) increase in book overdrafts	(2,825)	4,710
Payments of financing fees for debtor-in-possession financing	(1,415)
Deferred financing fees		(21)
Dividends paid on preferred stock		(7,000)
Proceeds from exercises of stock options		28
Net cash used in financing activities	(8,010)	(5,710)
Net decrease in cash and cash equivalents	(40,476)	(81,664)
Cash and cash equivalents at beginning of period	352,607	252,426
Cash and cash equivalents at end of period	312,131	170,762
ADJUSTMENTS TO RECONCILE NET LOSS TO NET CASH USED IN OPERATING ACTIVITIIES:
Depreciation and amortization	59,444	70,379
Impairment of long-lived assets	55,418	5,890
Nonoperating income	(83)	(8,277)
Non-cash interest expense	3,726	12,785
Stock compensation expense (income)	491	(861)
Pension withdrawal costs	13,923
Employee benefit related costs	3,672	1,965
LIFO adjustment	1,122	856
Asset disposition initiatives in the normal course of business	64,662
Asset disposition initiatives relating to discontinued operations		4
Non-cash occupancy charges for locations closed in the normal course of business	813	466
(Gains) losses on disposal of owned property and write-down of property, net	(146)	1,025
Amortization of deferred real estate income	(1,030)	(1,371)
Gain on disposal of discontinued operations		(79)
Gain on sale of pharmacy assets	(2,821)
C&S contract effect	6,986
Provision for deferred income taxes	(1,719)
Reorganization items, net relating to continuing operations	(77,878)
Reorganization items, net relating to discontinued operations	(34,194)
Financing fees	504
Total adjustments to net loss	$ 92,890	$ 82,782